Genmab A/S Total Liabilities

Latest as of September 2025: Dkr1.27 Billion DKK ≈ $198.70 Million USD

Genmab A/S total liabilities. Based on the latest financial reports, Genmab A/S (GMAB) has total liabilities worth Dkr1.27 Billion DKK (≈ $198.70 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check GMAB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Genmab A/S (2002–2024)

Total liabilities of Genmab A/S from 2002 to 2024. This chart illustrates how Genmab A/S's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Genmab A/S's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Genmab A/S Competitors by Total Liabilities

The table below lists competitors of Genmab A/S ranked by their total liabilities.

Company	Country	Total Liabilities
RWE AG XETRA:RWE	Germany	€58.53 Billion
DEUTSCHE BOERSE ADR 1/10 F:63DA	Germany	€353.25 Billion
CTBC Financial Holding Co Ltd Pref TW:2891B	Taiwan	NT$8.51 Trillion
CBRE Group Inc Class A NYSE:CBRE	USA	$21.31 Billion
Zscaler Inc NASDAQ:ZS	USA	$4.52 Billion
UTD OV. BK-LOC-ADR/1 SD 1 F:UOB0	Germany	€520.57 Billion
Bayerische Motoren Werke Aktiengesellschaft XETRA:BMW	Germany	€166.41 Billion
Chipotle Mexican Grill Inc NYSE:CMG	USA	$6.40 Billion

Liability Composition Analysis (2002–2024)

This chart breaks down Genmab A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see GMAB asset base.

Liquidity & Leverage Metrics

Genmab A/S Total Liabilities Ratios Explained

Genmab A/S total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	6.03	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genmab A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genmab A/S (2002–2024)

The table below shows the annual total liabilities of Genmab A/S from 2002 to 2024.

Year	Total Liabilities	Change
2024-12-31	Dkr9.11 Billion ≈ $1.43 Billion	+147.73%
2023-12-31	Dkr3.68 Billion ≈ $575.61 Million	+29.68%
2022-12-31	Dkr2.84 Billion ≈ $443.87 Million	+16.70%
2021-12-31	Dkr2.43 Billion ≈ $380.35 Million	+20.23%
2020-12-31	Dkr2.02 Billion ≈ $316.36 Million	+84.49%
2019-12-31	Dkr1.10 Billion ≈ $171.48 Million	+145.39%
2018-12-31	Dkr446.64 Million ≈ $69.88 Million	+35.04%
2017-12-31	Dkr330.75 Million ≈ $51.75 Million	-19.63%
2016-12-31	Dkr411.54 Million ≈ $64.39 Million	-1.03%
2015-12-31	Dkr415.83 Million ≈ $65.06 Million	-50.13%
2014-12-31	Dkr833.74 Million ≈ $130.45 Million	-22.23%
2013-12-31	Dkr1.07 Billion ≈ $167.72 Million	-18.15%
2012-12-31	Dkr1.31 Billion ≈ $204.91 Million	+21.49%
2011-12-31	Dkr1.08 Billion ≈ $168.66 Million	-23.08%
2010-12-31	Dkr1.40 Billion ≈ $219.28 Million	+51.63%
2009-12-31	Dkr924.34 Million ≈ $144.62 Million	-13.64%
2008-12-31	Dkr1.07 Billion ≈ $167.47 Million	-0.48%
2007-12-31	Dkr1.08 Billion ≈ $168.27 Million	+445.81%
2006-12-31	Dkr197.05 Million ≈ $30.83 Million	-21.70%
2005-12-31	Dkr251.66 Million ≈ $39.37 Million	+176.79%
2004-12-31	Dkr90.92 Million ≈ $14.23 Million	-2.94%
2003-12-31	Dkr93.67 Million ≈ $14.66 Million	-49.08%
2002-12-31	Dkr183.97 Million ≈ $28.78 Million	--

About Genmab A/S

CO:GMAB Denmark Biotechnology

Market Cap

$37.70 Billion

Dkr240.98 Billion DKK

Market Cap Rank

#710 Global

#4 in Denmark

Share Price

Dkr3912.00

Change (1 day)

+3.27%

52-Week Range

Dkr1524.00 - Dkr3912.00

All Time High

Dkr3912.00